104th Day Of Lockdown

Maharashtra2119871152629026 Tamil Nadu114978665711571 Delhi100823720883115 Gujarat36858263231967 Uttar Pradesh2770718761785 Telangana2390212703295 Karnataka234749849372 West Bengal2212614711757 Rajasthan2026315965459 Andhra Pradesh200198920239 Haryana1750413335276 Madhya Pradesh1528411579617 Bihar12140901497 Assam11737743414 Odisha9526648648 Jammu and Kashmir84295255132 Punjab64914494132 Kerala5623334128 Chhatisgarh3207257814 Uttarakhand3161258642 Jharkhand2815204520 Goa181310617 Tripura158012061 Manipur13897330 Himachal Pradesh107074610 Puducherry101148014 Nagaland5782280 Chandigarh4874016 Arunachal Pradesh269781 Mizoram191130 Sikkim125650 Meghalaya80431
Lifestyle Health and Wellbeing 15 Apr 2016 Heart cells can now ...

Heart cells can now be controlled using laser radiation

PTI
Published Apr 15, 2016, 5:53 pm IST
Updated Apr 15, 2016, 5:52 pm IST
This finding could potentially lead to an effective treatment for arrhythmias, a condition that causes irregular heartbeats.
Functional disorders in the heart muscles, particularly arrhythmia (an irregular heartbeat), are among the most common cardiac pathologies. (Photo: Pixabay)
 Functional disorders in the heart muscles, particularly arrhythmia (an irregular heartbeat), are among the most common cardiac pathologies. (Photo: Pixabay)

Moscow: Scientists have found how to control the behaviour of heart muscle cells using laser radiation, an advance that may lead to better understanding of the heart's mechanisms and help treat arrhythmia or irregular heartbeat.

"Right now this result may be very useful for clinical studies of the mechanisms of the heart, and in the future we could potentially stop attacks of arrhythmia in patients at the touch of a button," said Konstantin Agladze, head of Moscow Institute of Physics and Technology (MIPT)'s Laboratory of the Biophysics of Excitable Systems.

 

Functional disorders in the heart muscles, particularly arrhythmia (an irregular heartbeat), are among the most common cardiac pathologies. One in eight deaths in the world is caused by acute arrhythmia, researchers said. In order to study this type of heart disorder, it is important to be able to create "arrhythmia in vitro," which is what azoTAB (azobenzene trimethylammonium bromide - a modified version of azobenzene) is used for.

An azoTAB molecule can exist in two states, switching between them under the influence of radiation. Agladze and his colleagues "taught" the azoTAB molecules
to control cardiomyocytes so that one configuration did not prevent voluntary contractions (passive), and the other (active) "deactivated" contractions.

Using a device similar to a projector, but with a laser instead of a lamp, the scientists created at each point the required concentration of the active form of azoTAB. This enabled them to control the cardiomyocytes in each specific point of the heart. However, the precise mechanism of action of azoTAB on the cells remained unclear.

The scientists have now been able to explain how the different forms of azoTAB affect cardiomyocytes. Ion channels are used to transfer "commands" from one
cell to another; they act as "gates" allowing ions to pass through cell membranes.
In cardiomyocytes there are various types of channels capable of allowing potassium, sodium or calcium ions to pass. The scientists conducted an experiment on heart muscle cells that were placed in a solution of azoTAB in two
different concentrations.

They were then exposed to light of different wavelengths in the range of near-UV light. When each of the channels was examined, the two others were deactivated using inhibitor substances and cardiomyocytes were isolated from one another.
It was found that after three minutes of exposure to the active form of azoTAB, the current through the calcium and sodium channels reduced by more than two times, and in the potassium channel it increased one and a half times.

After the azoTAB was removed by washing the cells, the function of ion channels quickly returned to its normal state. The experiment showed that the effect of azoTAB on a cell is reversible. This will mean that the results of the experiments will be able to be used in research and clinical practice, which could potentially lead to an effective treatment for arrhythmias. The research was published in the journal PLOS ONE.

...




ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT